DoD Traumatic Brain Injury and Psychological Health, Investigator-Initiated Research Award | W81XWH 21 TBIPHRP IIRA

Opportunity Information: Apply for W81XWH 21 TBIPHRP IIRA

The DoD Traumatic Brain Injury and Psychological Health (TBIPHRP) Investigator-Initiated Research Award (IIRA) is a FY21 funding opportunity from the Department of Defense (USAMRAA) meant to support impactful research that improves how the field understands, prevents, and treats traumatic brain injury (TBI) and/or psychological health conditions. The program is intentionally broad in terms of scientific scope and allows projects anywhere along the research pipeline, from basic laboratory studies through translational and preclinical work, including studies in animal models and research involving human subjects. It also allows correlative or ancillary studies that are tied to an existing clinical trial, as long as the proposed work itself is not running a trial.

A central constraint is that this award cannot be used to conduct a clinical trial. In this announcement, a clinical trial is defined in the standard way: a study where one or more human subjects are prospectively assigned to one or more interventions (including placebo or controls) to evaluate effects on biomedical or behavioral health outcomes. If a project involves prospective assignment to an intervention to test outcomes, it belongs in other TBIPHRP mechanisms (for example, the Clinical Trial Award, Focused Program Award, or Translational Research Award listed in the notice), not this IIRA. Human subjects research is still allowed under the IIRA, including studies using human anatomical substances, but applicants must stay on the non-trial side of the line (for example, observational clinical research, mechanistic studies in people, epidemiology, behavioral research, outcomes and health services research, or technology development that does not constitute a trial). The announcement also clarifies a nuance used by CDMRP: projects that qualify for IRB Exemption 4 (research using existing de-identified specimens or data, publicly available or otherwise) are not considered CDMRP-defined clinical research. In addition, the IIRA cannot support studies that would require an exception from informed consent.

The award is positioned for research that is investigator-initiated but expected to be high impact. Applications are expected to make a clear case for why the work could produce major advances, not incremental findings. Reviewers will be looking for a strong explanation of both near-term and long-term outcomes or products, which could be new knowledge, tools, technologies, or other tangible deliverables, and a convincing argument for how those outputs would address a critical problem in TBI and/or psychological health within the program’s stated focus areas. Preliminary data are required, meaning applicants need to include relevant supporting evidence for feasibility and rationale. Unpublished preliminary data are allowed, but the notice emphasizes that these should come from the PI’s lab or the research team, not be purely speculative or dependent on outside unpublished work.

Military health relevance is treated as a core feature rather than an optional add-on. Competitive proposals should explicitly connect the research to the needs of Service Members, Veterans, military beneficiaries, and, by extension, the broader public. The program gives concrete ways to demonstrate this, such as showing how the project relates to readiness or health impacts seen in military populations, proposing dual-use outputs that could benefit both civilian and military settings, using military or Veteran datasets/samples when appropriate, or incorporating collaboration with DoD or VA investigators. The announcement strongly encourages alignment with DoD and VA laboratories and programs, and it notes that collaborations between military/Veterans institutions and non-military institutions are valued because they can combine infrastructure, expertise, and access to unique populations or resources.

A notable feature is an Early-Career Investigator partnering option that allows two-PI applications. Under this structure, one PI serves as the Initiating PI (handling most submission administration) and the other is the Partnering PI; either one can be the Early-Career Investigator. The application is expected to justify the partnership in a substantive way, describing what each PI uniquely contributes, why the combined expertise is necessary for the strategy and the statement of work, and why the work is better done together than as separate projects. If selected, each PI would be named on an individual award at their respective organizations, reflecting the program’s intent to support true collaborative leadership rather than a token co-investigator arrangement.

From an administrative and funding standpoint, awards are issued as assistance agreements, meaning the government is supporting a public purpose rather than purchasing a service for direct government use. Depending on anticipated DoD involvement during performance, the agreement may be a grant (if no substantial involvement is expected) or a cooperative agreement (if substantial involvement, such as collaboration or participation in the research, is expected). The maximum budget for total costs across the full period of performance is capped at $750,000 per award. For the FY21 cycle described, the program planned to allocate about $11.25 million total to fund roughly 15 awards, with actual funding dependent on federal funds availability and the outcome of scientific and programmatic review. The opportunity was posted in August 2021 with an original closing date of September 30, 2021, and awards were expected to be made no later than September 30, 2022. Funds associated with FY21 awards were anticipated to expire for use on September 30, 2027, which sets an outer boundary on how long the FY21 appropriated funds remain available for obligation and expenditure under the award structure.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Traumatic Brain Injury and Psychological Health, Investigator-Initiated Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Aug 06, 2021.
• Applicants must submit their applications by Sep 30, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 15 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 TBIPHRP IIRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: